A Prospective, Non-interventional, Observational Study To Describe the Effectiveness of Trandolapril (Mavik) in the Management of Patients Requiring Angiotensin Converting Enzyme Inhibitor Treatment.

Trial Profile

A Prospective, Non-interventional, Observational Study To Describe the Effectiveness of Trandolapril (Mavik) in the Management of Patients Requiring Angiotensin Converting Enzyme Inhibitor Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2012

At a glance

  • Drugs Trandolapril (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms in-MAU-tion
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 17 Jan 2012 Actual patient number changed from 8001 to 7993 as reported by ClinicalTrials.gov.
    • 02 Dec 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
    • 02 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top